|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.8 TWD | -0.63% |
|
-1.56% | -9.20% |
| Apr. 19 | InnoPharmax Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | InnoPharmax Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
InnoPharmax Inc. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was TWD 14.69 million compared to TWD 28.39 million a year ago. Net loss was TWD 48.87 million compared to TWD 41.28 million a year ago.
Basic loss per share from continuing operations was TWD 0.56 compared to TWD 0.48 a year ago. Diluted loss per share from continuing operations was TWD 0.56 compared to TWD 0.48 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -9.20% | 46.15M | |
| +15.94% | 41.97B | |
| +22.56% | 22.34B | |
| +16.44% | 15.25B | |
| +16.49% | 14B | |
| +49.37% | 12.06B | |
| -10.77% | 6.8B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +14.18% | 5.49B |
INNOPHARMAX INC. 
